hTERT is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins

Clinical Orthopaedics and Related Research

Volumn 426, Issue , 2004, Pages 64-68

  Fuchs, Bruno ^a,b   Inwards, Carrie ^a   Scully, Sean P ^a   Janknecht, R ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EWS ETS ONCOPROTEIN; HYBRID PROTEIN; ONCOPROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; CANCER SURVIVAL; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME ACTIVATION; EWING SARCOMA; FEMALE; FOLLOW UP; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TREATMENT OUTCOME;

EID: 4444233211     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000141385.77071.8d     Document Type: Conference Paper

References (46)

1. Arndt CA, Crist WM: Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341:342-352, 1999.
2. Arvand A, Denny CT: Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20:5747-5754, 2001.
3. Bredemeier-Ernst I, Nordheim A, Janknecht R: Transcriptional activity and constitutive nuclear localization of the ETS protein Elf-1. FEBS Lett 408:47-51, 1997.
4. de Alava E, Kawai A, Healey JH, et al: EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16:1248-1255, 1998.
5. Delattre O, Zucman J, Plougastel B, et al: Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165, 1992.
6. Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Rettig WJ: Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2. Am J Pathol 139:317-325, 1991.
7. Feng J, Funk WD, Wang SS, et al: The RNA component of human telomerase. Science 269:1236-1241, 1995.
8. Fuchs B, Inwards CY, Janknecht R: Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins, c-Jun and p300. FEBS Lett 553: 104-108, 2003.
9. Fuchs B, Inwards CY, Janknecht R: VEGF Expression is upregulated by EWS-ETS oncoproteins and Sp1 and represents an independent predictor of survival in Ewing's sarcoma. Clin Cancer Res, 2004. (In press)
10. Fuchs B, Valenzuela RG, Inwards C, Sim FH, Rock MG: Complications in long-term survivors of Ewing sarcoma. Cancer 98:2687-2692, 2003.
11. Grier HE, Krailo MD, Tarbell NJ, et al: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694-701, 2003.
12. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70, 2000.
13. Hiyama E, Gollahon L, Kataoka T, et al: Telomerase activity in human breast tumors. J Natl Cancer Inst 88:116-122, 1996.
14. Hiyama E, Hiyama K, Yokoyama T, et al: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1: 249-255, 1995.
15. Hiyama E, Kodama T, Shinbara K, et al: Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57:326-331, 1997.
16. Hiyama K, Hiyama E, Ishioka S, et al: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87:895-902, 1995.
17. Holt SE, Shay JW: Role of telomerase in cellular proliferation and cancer. J Cell Physiol 180:10-18, 1999.
18. Horikawa I, Cable PL, Mazur SJ, et al: Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: Evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell 13:2585-2597, 2002.
19. Jeon IS, Davis JN, Braun BS, et al: A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10:1229-1234, 1995.
20. Kaneko Y, Yoshida K, Handa M, et al: Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 15:115-121, 1996.
21. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 75:457-481, 1958.
22. Khan J, Wei JS, Ringner M, et al: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7:673-679, 2001.
23. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
24. Kinsella TJ, Miser JS, Waller B, et al: Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy. Int J Radiat Oncol Biol Phys 20:389-395, 1991.
25. Kumar R, Schaefer J, Grande JP, Roche PC: Immunolocalization of calcitriol receptor, 24-hydroxylase cytochrome P- 450, and calbindin D28k in human kidney. Am J Physiol 266:F477-F485, 1994.
26. Ladanyi M: EWS-FLI1 and Ewing's sarcoma: Recent molecular data and new insights. Cancer Biol Ther 1:330-336, 2002.
27. Langford LA, Piatyszek MA, Xu R, Schold Jr SC, Shay JW: Telomerase activity in human brain tumours. Lancet 346:1267-1268, 1995.
28. Lessnick SL, Dacwag CS, Golub TR: The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1:393-401, 2002.
29. Mackall CL, Meltzer PS, Helman LJ: Focus on sarcomas. Cancer Cell 2:175-178, 2002.
30. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G: Telomerase activity in human renal cell carcinoma. Oncogene 13:161-166, 1996.
31. Morales CP, Lee EL, Shay JW: In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 83:652-659, 1998.
32. Paulussen M, Ahrens S, Dunst J, et al: Localized Ewing tumor of bone: Final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19:1818-1829, 2001.
33. Peter M, Couturier J, Pacquement H, et al: A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159-1164, 1997.
34. Riley RD, Burchill SA, Abrams KR, et al: A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family. Eur J Cancer 39:19-30, 2003.
35. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791, 1997.
36. Sommerfeld HJ, Meeker AK, Piatyszek MA, et al: Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res 56:218-222, 1996.
37. Sorensen PH, Lessnick SL, Lopez-Terrada D, et al: A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6:146-151, 1994.
38. Unni KK: Ewing's Tumor. In Unni K (ed). Dahlin's Bone Tumors. General Aspects and Data on 11'087 Cases. Philadelphia, Lippincott-Raven 249-261, 1996.
39. Wai DH, Schaefer KL, Schramm A, et al: Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int J Oncol 20:441-451, 2002.
40. Welford SM, Hebert SP, Deneen B, Arvand A, Denny CT: DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis. J Biol Chem 276:41977-41984, 2001.
41. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179, 1996.
42. Wright WE, Shay JW: Cellular senescence as a tumor-protection mechanism: The essential role of counting. Curr Opin Genet Dev 11:98-103, 2001.
43. Yago M, Ohki R, Hatakeyama S, Fujita T, Ishikawa F: Variant forms of upstream stimulatory factors (USFs) control the promoter activity of human telomerase reverse transcriptase, the human gene encoding the catalytic subunit of telomerase. FEBS Lett 520:40-46, 2002.
44. Yashima K, Milchgrub S, Gollahon LS, et al: Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res 4:229-234, 1998.
45. Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al: Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 14:1245-1251, 1996.
46. Zucman J, Melot T, Desmaze C, et al: Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12:4481-4487, 1993.